Following weight loss, metabolic adaptation can occur, reducing energy expenditure more than anticipated, which can hinder long-term success (32)
The difference is: Ipamorelin: GHSR / ghrelin receptor pathway IGF-1 LR3: IGF-1R receptor tyrosine kinase pathway Ipamorelin: GH secretagogue marker research IGF-1 LR3: growth factor receptor signalling research Ipamorelin: peptide secretagogue IGF-1 LR3: modified IGF-1 analogue This distinction is useful for internal linking because BioPlex already has peptide research content on Ipamorelin and related myogenic pathway compounds
But researchers didn't stop there
It is worth being specific about why the single-laboratory concern is not merely academic pedantry
10.3389/fmicb.2022.889374 Front
Subsequent trials, including SUSTAIN-6, Harmony Outcomes, and AMPLITUDE-O, reported similar MACE reductions but without a mortality benefit [15,16,17]